Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are ...

Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank Mesoblast for inspiring the third.

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

HQH trades at an 8% discount to NAV, offering an attractive entry point compared to peers, despite recent price declines.

A webcast of the presentation can be found under the IR Events tab of the Tonix website at .

For centuries, the default subject in medicine research and training has been the male. Julia Robinson talks to the ...

Virginians will determine who will represent the Democratic Party in Virginia’s lieutenant governor and attorney general ...